International Flavors & Fragrances Inc
Change company Symbol lookup
Select an option...
IFF International Flavors & Fragrances Inc
NEMD iNeedMD Holdings Inc
CVS CVS Health Corp
CMI Cummins Inc
INVH Invitation Homes Inc
OII Oceaneering International Inc
SINO Sino-Global Shipping America Ltd
MLM Martin Marietta Materials Inc
KO Coca-Cola Co
VICI VICI Properties Inc

Materials : Chemicals | Mid Cap Blend
Company profile

International Flavors & Fragrances Inc. provides products that consumers taste, smell, or touch. It operates through three segments: Taste, Frutarom and Scent. Taste is comprised of Flavor Compounds which are sold to the food and beverage industries for use in consumer products, such as prepared foods, beverages, dairy, food and sweet products. Frutarom segment creates and manufactures a naturals-focused suite of flavor compounds, functional foods and specialty fine ingredients. Scent segment is comprised of Fragrance Compounds, which are used by its customers in two broad categories: Fine Fragrances and Consumer Fragrances; Fragrance Ingredients, which consists of synthetic and natural ingredients that can be combined with other materials to create fragrance and consumer compounds; and Cosmetic Active Ingredients, consisting of active and functional ingredients, botanicals and delivery systems.

Closing Price
Day's Change
-0.26 (-0.25%)
B/A Size
Day's High
Day's Low

10-day average volume:

Humana's stock set to rally after profit, revenue rise above expectations

6:47 am ET August 5, 2020 (MarketWatch)

Shares of Humana Inc. (HUM) were indicated up nearly 3% in premarket trading Wednesday, after the health care services company reported second-quarter profit and revenue that beat expectations, while maintaining its adjusted earnings outlook. Net income rose to $2.59 billion, or $13.75 a share, from $1.07 billion, or $6.94 a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share rose to $12.56 from $6.05, above the FactSet consensus of $10.27. Revenue grew 17.5% to $19.08 billion, topping the FactSet consensus of $18.64 billion. The company said as a result of the COVID-19 pandemic, admissions and utilization were "significantly depressed" in April, then increased through May and June, and were "modestly below normal" at the end of the quarter. Humana affirmed its 2020 adjusted EPS guidance range of $18.25 to $18.75, but nudged up its full-year individual Medicare Advantage membership growth outlook to 330,000 to 360,000 members from 300,000 to 350,000 members. The stock has gained 6.7% year to date through Tuesday, while the SPDR Health Care Select Sector ETF (XLV) has tacked on 4.2% and the S&P 500 has gained 2.3%.

-Tomi Kilgore; 415-439-6400;

(END) Dow Jones Newswires

August 05, 2020 06:47 ET (10:47 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.